Publications by authors named "Jeffry Simko"

Claim this Profile
I
In reply to: 'Prostate cancer with favorable histology is not synonymous with prostate cancer indolence'.
Jesse K McKenney, James D Brooks, Jane K Nguyen, C K Cornelia Ding, Lisa F Newcomb, Jeffry P Simko

Histopathology· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of lymphocytic infiltration and degree of pleomorphism with tumor mutation burden in high-grade urothelial carcinoma.
Neslihan Kayraklioglu, Li Zhang, Chien-Kuang Cornelia Ding, Nancy Y Greenland, Bradley A Stohr, Jeffry P Simko

Hum Pathol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of a Multimodal Artificial Intelligence-derived Digital Pathology-based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG Trials.
Todd M Morgan, Yi Ren, Siyi Tang, Wouter Zwerink, Emmalyn Chen, Jeffry P Simko

Eur Urol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III Trials.
Andrew J Armstrong, Vinnie Y T Liu, Ramprasaath R Selvaraju, Emmalyn Chen, Jeffry P Simko

J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classification of prostatic adenocarcinoma as favourable/unfavourable histology has high interobserver agreement in prostate needle core biopsies.
Chien-Kuang C Ding, Huijun Xiao, Jane K Nguyen, Christopher G Przybycin, Reza Alaghehbandan, Jeffry P Simko

Histopathology· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy.
Emily Chan, Stephanie L Pugh, Jeffry P Simko, Felix Feng, William U Shipley

Prostate· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of unfavourable and favourable histology at radical prostatectomy with Decipher scores and freedom from biochemical recurrence.
Nancy Y Greenland, Janet E Cowan, Chien-Kuang Cornelia Ding, Deepika Sirohi, Matthew R Cooperberg, Jeffry P Simko

Histopathology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III Trials.
Mack Roach, Jingbin Zhang, Osama Mohamad, Douwe van der Wal, Jeffry P Simko

JCO Clin Cancer Inform· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gleason Grade Group 3 Represents a Spectrum of Disease: Results from a Large Institutional Cohort.
Kevin Shee, Janet E Cowan, Chien-Kuang Cornelia Ding, Lufan Wang, William Pace, Jeffry P Simko

Eur Urol Focus· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced Restriction Imaging and Reconstruction Technology for Prostate Magnetic Resonance Imaging (ART-Pro): A Study Protocol for a Multicenter, Multinational Trial Evaluating Biparametric Magnetic Resonance Imaging and Advanced, Quantitative Diffusion Magnetic Resonance Imaging for the Detection of Prostate Cancer.
Madison T Baxter, Christopher C Conlin, Aditya Bagrodia, Tristan Barrett, Hauke Bartsch, Jeffry P Simko

Eur Urol Open Sci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-generation sequencing has diagnostic utility in challenging small/flat urothelial lesions.
Amélie Pinard, Constance Chen, Jessica Van Ziffle, Jeffry P Simko, Bradley A Stohr

Ann Diagn Pathol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of benign tissue within cancerous regions in the prostate: Characterizing sparse and dense prostate cancers on whole-mount histopathology and on multiparametric MRI.
Olga Starobinets, Jeffry P Simko, Matthew Gibbons, John Kurhanewicz, Peter R Carroll

Magn Reson Imaging· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Spratt DE, Liu VYT, Michalski J, Davicioni E, Berlin A, Simko JP, Efstathiou JA, Tran PT, Sandler HM, Hall WA, Thompson DJS, Parliament MB, Dayes IS, Correa RJM, Robertson JM, Gore EM, Doncals DE, Vigneault E, Souhami L, Karrison TG, Feng FY. Genomic classifier performance in intermediate-risk prostate cancer: results from NRG Oncology/RTOG 0126 randomized phase 3 trial. Int J Radiat Oncol Biol Phys 2023;117:370-377.
Daniel E Spratt, Vinnie Y T Liu, Jeff Michalski, Elai Davicioni, Alejandro Berlin, Jeffry P Simko

Int J Radiat Oncol Biol Phys· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials.
Krishnan R Patel, Paul L Nguyen, James A Proudfoot, Yang Liu, Alan Dal Pra, Jeffry P Simko

Eur Urol Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 Trial.
Ashley E Ross, Jingbin Zhang, Huei-Chung Huang, Rikiya Yamashita, Jessica Keim-Malpass, Jeffry P Simko

Eur Urol Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712.
Zaker Rana, Sophia C Kamran, Amol C Shetty, Philip Sutera, Yang Song, Jeffry P Simko

Eur Urol Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital Histopathology.
Jonathan David Tward, Huei-Chung Huang, Andre Esteva, Osama Mohamad, Douwe van der Wal, Jeffry P Simko

JCO Precis Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morphologic patterns observed in prostate biopsy cases with discrepant grade group and molecular risk classification.
Nancy Y Greenland, Matthew R Cooperberg, Peter R Carroll, Janet E Cowan, Jeffry P Simko

Prostate· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mixed Supervision of Histopathology Improves Prostate Cancer Classification From MRI.
Abhejit Rajagopal, Antonio C Westphalen, Nathan Velarde, Jeffry P Simko, Hao Nguyen

IEEE Trans Med Imaging· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable-risk prostate cancer.
Avery E Braun, June M Chan, John Neuhaus, Janet E Cowan, Stacey A Kenfield, Jeffry P Simko

Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large cribriform glands (> 0.25 mm diameter) as a predictor of adverse pathology in men with Grade Group 2 prostate cancer.
Nancy Y Greenland, Janet E Cowan, Bradley A Stohr, Jeffry P Simko, Peter R Carroll

Histopathology· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human Evaluation of a Prostate-specific Membrane Antigen-targeted Near-infrared Fluorescent Small Molecule for Fluorescence-based Identification of Prostate Cancer in Patients with High-risk Prostate Cancer Undergoing Robotic-assisted Prostatectomy.
Hao G Nguyen, Nynke S van den Berg, Alexander L Antaris, Lingru Xue, Scott Greenberg, Jeffry P Simko

Eur Urol Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positive NKX3.1 as a diagnostic pitfall for prostate cancer in extramammary Paget's disease of genitourinary sites.
Constance V Chen, Rony A Francois, Thaddeus W Mully, Ankur Sangoi, Philip E LeBoit, Jeffry P Simko

Histopathology· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker.
Shiqin Liu, Sarah J Hawley, Christian A Kunder, En-Chi Hsu, Michelle Shen, Jeffry Simko

Sci Rep· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer.
Daniel E Spratt, Siyi Tang, Yilun Sun, Huei-Chung Huang, Emmalyn Chen, Jeffry P Simko

NEJM Evid· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis